LPL Financial »

Halozyme Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2M 55k 40.68
2023-09-30 $1.6M 43k 38.20
2023-06-30 $1.4M 38k 36.07
2023-03-31 $1.2M 30k 38.19
2022-12-31 $1.1M 20k 56.90
2022-09-30 $588k 15k 39.51
2022-06-30 $726k 17k 44.01
2022-03-31 $577k 15k 39.91
2021-12-31 $989k 25k 40.22
2021-09-30 $704k 17k 40.65
2021-06-30 $797k 18k 45.40
2021-03-31 $645k 16k 41.68
2020-12-31 $448k 11k 42.72
2020-09-30 $263k 10k 26.29
2020-06-30 $1.0M 38k 26.81